New startup ideas · Health and bio · Healthcare and bio

startup idea

Halomark

A wearable that reads hormones continuously, the way CGMs read glucose.

Halomark builds a subcutaneous aptamer-based sensor and patch reader that tracks cortisol, thyroid and reproductive hormones continuously instead of at single blood-draw timepoints.

Hardware
Consumer
$1-10B market
Creates a new category
US first

3/5

venture judge

similar startups, last 2 years (74 all-time)

95%

of 2 nearest real companies still alive

yes

8 matching federal grants and programs

Direction supported by government programs and grants

Test it before you build it

$1,500 · 3 weeks · 30 prospects

For $1,500 in 3 weeks, prove that perimenopausal women who already pay for contradictory hormone panels will put down $100 today for a continuous hormone patch that does not exist yet.

Riskiest assumption · Women who already pay hundreds of dollars for repeated single-timepoint hormone panels will hand over money today for a continuous hormone curve at $89 per month, rather than treating it as interesting but not worth paying for until it exists and is proven accurate.

1Focus group: who and where

Women aged 40-55 in perimenopause who have paid out of pocket for at least two hormone panels (Everlywell, LetsGetChecked, Quest self-pay, or a functional medicine doctor) in the past 12 months and got results that disagreed with each other or with how they feel.

where to find 30 · The r/Perimenopause and r/Menopause subreddits, where paying for repeat panels is a weekly complaint thread; the audiences of menopause creators on TikTok and Instagram such as Dr. Mary Claire Haver, reachable through comment sections and paid placements; the review sections of at-home hormone test kits (Everlywell and LetsGetChecked on Trustpilot), where buyers describe exactly the single-timepoint frustration this product attacks.

2Sell first, build later

A founding-cohort spot for the Halomark patch and reader: continuous cortisol and estradiol curves in an app, positioned as general wellness, first 500 units shipping within 18 months, founding price locked for year one.

the ask · $89 per month subscription plus the reader, held by a $100 refundable reservation

a real yes · A real yes is a completed $100 card payment on the reservation page. Waitlist emails, upvotes, comments saying 'I need this', and interviewees who praise the idea but do not pay are not yeses.

3Small experiments

The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.

1. Paid panel-buyer interviews
$600 · 7 days
Post a research recruit in r/Perimenopause and r/Menopause offering a $40 gift card for a 20-minute Zoom call, screening for women who paid for 2+ hormone panels in the past year. One founder runs 15 calls in a week, asking what they paid, what the results contradicted, and what a continuous curve would change about their next doctor visit.
keep going if · 10 of 15 interviewees spent $300+ on hormone testing in the past year and describe a specific decision the contradictory results blocked
2. Direct reservation offer
$100 · 7 days
At the end of each interview, make the offer live: Halomark, cortisol and estradiol curves from a patch, $89 per month founding price, first cohort ships within 18 months, held by a $100 fully refundable reservation. Send the checkout link while still on the call and ask each yes for two referrals.
keep going if · 5 of 15 interviewees pay the $100 reservation on or within 48 hours of the call
3. Cold-traffic reservation page
$800 · 10 days
Run a priced landing page with the same $100 reservation against $800 of Instagram and Facebook ads targeted at US women 40-55 interested in menopause and hormone health, using interview language verbatim in the ad copy. This tests whether strangers, not warm interviewees, convert.
keep going if · 8 or more paid reservations at a blended ad cost under $120 per reservation

4Collect a deposit up front

Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.

$100

per prospect, refundable

how · A $100 refundable consumer reservation taken through the landing page checkout, the standard instrument for a hardware pre-launch to this buyer: it is small enough to pay on impulse from a phone but large enough that only real intent converts. The buyer clicks, pays, and gets a numbered cohort spot by email; no contract is signed. set up: Stripe Checkout ↗

what it reserves · A numbered spot in the first 500-unit cohort and the $89 per month founding price locked for the first year

refund · Fully refundable with one click any time before the unit ships, and refunded automatically if nothing ships within 18 months.

target · 13 paid reservations (5 from 15 interviews, 8 from cold traffic) within 21 days

before taking money · Do not implant, ship, or make any diagnostic or treatment claim for the device before FDA clearance; take only refundable reservations under general wellness language reviewed by an FDA regulatory attorney.

Go: build it if

13+ paid $100 reservations in 3 weeks, with cold-traffic cost per reservation under $120 and at least 10 of 15 interviewees confirming $300+ annual panel spend: demand is proven and the remaining bet is the sensor chemistry, which is where the seed round goes.

Kill: stop if

Fewer than 3 total reservations after 15 interviews and $800 of ads, or cold-traffic cost per reservation above $250: the panel frustration is real but not worth prepaid money, and the category claim fails on the buyer before it ever reaches the aptamer problem.

5 Scripts to run itoutreach message, landing copy, deposit terms · click to open

outreach message

You have probably paid for more than one hormone panel that told you a different story each time. I am building a wearable patch that tracks cortisol and estradiol continuously, the way a CGM tracks glucose, so you see your curve instead of one morning's number. I am interviewing 15 women who paid for hormone testing in the past year: 20 minutes on Zoom, $40 Amazon gift card, no sales pitch. Can I book you this week?

landing page

See your hormone curve, not one blood draw A $100 refundable reservation locks the $89 per month founding price and a spot in the first 500-unit cohort Reserve your Halomark for $100

deposit terms

Your $100 reservation holds a numbered spot in our first cohort of 500 and locks the $89 per month founding price for your first year. It is fully refundable with one click any time before your unit ships, and refunds automatically if we have not shipped within 18 months. Halomark is in development as a general wellness product and no medical claims are made.

Would you run this test?

One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.

Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.

Scorecard

One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.

Idea Score, 0-100 · raw 32.3 x 1.61

Crowded

competition: more crowded than 88% of ideas · headwind x0.56

+3.9

government priorities, secondary (42 matching grants)

Trend

Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.

Entrants 2025-26 vs 2023-24 (similar companies)51
Rounds announced 2025+ in the sector69
Sector direction (live batch)100
2026 trend analyst0

Demand

Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.

YC asks for it (current RFS: idea / sector)30
Someone already pays (similar companies, recent / all-time)100
Operator judge: real pain0

100x potential

Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.

Venture judge50
Market size axis33
Moat axis80
Neighbours still alive65
Technologist judge50

Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were wearable, reads, hormones, continuously, cgms, read, glucose, builds.

The idea in full

What: Halomark builds a subcutaneous aptamer-based sensor and patch reader that tracks cortisol, thyroid and reproductive hormones continuously instead of at single blood-draw timepoints. Consumers buy it directly online on a subscription, the way glucose monitors are now bought, and see hormone curves rather than one number from one morning. The hard part is sensor chemistry stability in interstitial fluid plus the fab line to make patches at consumer prices.
Why now: Sub-Q Bionics raised $1.5M pre-seed on 2026-04-01 for subcutaneous biomedical technology and Illume Labs (yc S26) is selling a 24/7 personal health and longevity companion with no continuous chemistry underneath it, so the consumer demand and the sensing substrate are arriving at the same time.
Wedge: first customer and entry point: Perimenopausal women who currently pay for repeated single-timepoint hormone panels that contradict each other: one analyte, direct-to-consumer, general wellness positioning while the de novo submission runs.
Path to 100x: Continuous hormone measurement is a $1-10B market today because it does not exist as a purchasable thing, and the company that names and owns it takes the position CGM makers took when glucose curves became a consumer product. The moat is the direct subscription channel: hundreds of thousands of recurring patch buyers acquired before any incumbent has a cleared competing sensor.
Ceiling: FDA holds the consumer claim to wellness-only language and cartridge cost stays high, leaving a high-priced enthusiast product rather than a category.
Closest real companies, as the generator saw them: Sub-Q Bionics works on subcutaneous biomedical hardware but not a consumer-owned continuous hormone product; Illume Labs and Gutgutgoose (yc S26) sell consumer health subscriptions on top of external data rather than generating their own continuous signal.
Main risk: Aptamer sensors drift within days in vivo, so the curve is uncalibrated after week one and the whole category claim collapses.

Five judges

Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).

Venture investor
3/5
CGM-scale category creation is the right shape, but aptamer drift within days makes the whole thesis a single binary science bet.
Bootstrapper
1/5
Subcutaneous aptamer sensors, a fab line and an FDA de novo submission is the maximum capital and regulatory path available.
Operator
1/5
No line item exists for continuous hormone curves today, and aptamer drift within days means the subscription has nothing to sell.
Technologist
3/5
Aptamer sensors that drift within days in interstitial fluid means the product hinges on a stability breakthrough that does not exist today.
Risk
1/5
Selling a subcutaneous hormone sensor direct to consumers under wellness language while the de novo runs is unlicensed exposure on an implanted device.
trends
1/5
A $1.5M pre-seed at Sub-Q Bionics is the entire timing case; continuous hormone sensing chemistry has no 2025-2026 unlock in evidence.

Similar startups in the directory

Companies whose pitch matches most of the idea's terms (wearable, reads, hormones, continuously, cgms, read, glucose, builds): 74 all-time, 29 from the last two years. Same matching as Idea Check.

Moonshotyc S26 · 2026 · Consumeralive
agents for the rest of us
RonanRx Inc.yc S26 · 2026 · Healthcare and bioalive
Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1s
Amborasyc X26 · 2026 · Vertical AI agentsalive
AI Native Shopify
Clair Healthspeedrun SR006 · 2026 · Healthcare and bioalive
We're building the first continuous hormone monitor.
Nessieyc F25 · 2025 · Agent infrastructurealive
The shared context layer for recursive companies - your work, your…
CommodityAIyc W24 · 2024 · Vertical AI agentsunchecked
The AI operating system for commodity operations
BirdShadessosv SOSV IndieBio RebelBio 07 · 2018 · Robotics and physical worldalive
We give birds the vision to stop window collisions
OneSpot, Inc.500global · 2012 · B2B SaaSacquired
Developer of a content marketing platform designed to personalize branded content across websites, email, paid media and more, The company's content marketing platform uses machine learning technology that automatically surfaces the most personally relevant content to the visitors across channels and continually improves content recommendations of the visitors to keep them coming back and reading more of the content. enabling brands to build strong content-based relationships, provide measurable audience and content insights and drive quantifiable results.
Mirrorsyc F26 · 2026 · Agent infrastructurealive
Give AI agents the right instructions at the right moment
Hesper AIyc F26 · 2026 · Vertical AI agentsalive
AI Claims Investigator for Insurance
Definiteyc F26 · 2026 · Vertical AI agentsalive
Build everyday back-office agents on one live model of your books
Papayayc F26 · 2026 · Agent infrastructurealive
Continuous optimization for AI agents

Run this as an Idea Check →

The generator's reference companies

Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.

Public money in this direction

US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.

grants and programs matching the idea

1596

startup-relevant grants in Healthcare and bio

$854M

awarded in the sector, tracked

119

opportunities open now in the sector

A Specialized Risk-Stratification Platform and Tailored Diabetes Prevention Program for Post-Partum to Reduce Progression to Type 2 Diabetesawardhigh relevance
NIH / NIMHD · SBIR phase II · $1M · posted 2025-09-17
A Specialized Risk-Stratification Platform and Tailored Diabetes Prevention Program for Post-Partum to Reduce Progression to Type 2 Diabetesawardhigh relevance
NIH / NIMHD · SBIR phase II · $314K · posted 2025-09-17
Development and Validation of Efficient Algorithms for Real-Time Glucose Monitoring on a Multi-Sensor Integrated Platformawardhigh relevance
NIH / NIDDK · SBIR phase I · $285K · posted 2025-09-01
MetaDx: Rapid Diagnosis of Fungal, Bacterial, and Viral Infections Using Whole Metagenomic Sequencingawardhigh relevance
NIH / NIAID · SBIR phase I · $295K · posted 2026-06-12
Data Collection and Analysis for Long-Term, Wireless Human Biosignal Sensing via Wearable Biosynthetic Sleeveawardhigh relevance
NIH / NHLBI · SBIR phase I · $314K · posted 2026-09-20
A Miniaturized and Flexible Continuous Glucose Monitoring Platform using Scalable Semiconductor Manufacturingawardhigh relevance
NIH / NIDDK · SBIR phase II · $923K · posted 2026-08-25
I-Corps: Translation Potential of a marine-adapted radio frequency identification (RFID) and analytics platform for digital inventory management in shellfish aquacultureawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-19
Wearable long duration postoperative topical cryotherapy for enhanced pain managementawardhigh relevance
NIH / NCCIH · SBIR phase I · $313K · posted 2026-08-17

All public money by sector →

Market signal

What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.

Healthcare and bio · 135 → 121 → 224 → 173 → 127 new companies 2022 → 2026 · 91% aliveYC F26 live: 2 in this cluster, 2% of the batch (was 6% in S26)Since February, of 442 YC companies here: 6 acquired, 6 shut down, 45 rewrote their pitch

Healthcare and bio: companies, trend and grants →

Design attributes

The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.

Buyer: Consumer
Business model: Hardware
Path to 100x: Creates a new category
Market size: $1-10B market
Capital intensity: Capital-heavy (hardware, bio, infra)
Speed to revenue: Revenue in 1-3 years
Technical depth: Deep tech: ML, hardware, bio
Go-to-market: Self-serve
Moat: Distribution moat
Geography: US first
Regulation: Heavily regulated
Vibe: Hot space